2026年の記事一覧

• Yoshimoto T, Hattori Y, Ishiyama H, Kiyoshige E, Ogata S, Nishimura K, Okada Y, Akaiwa Y, Kawamoto M, Ichijo M, Inoue H, Mizuno T, Tomimoto H, Kawakami D, Ihara M.
  Long-term outcomes in the pre-moyamoya stage of RNF213-related vasculopathy presenting with ischaemic stroke or transient ischaemic attack: insights from the NCVC Genome Registry
  Lancet Reg Health West Pac 2026; 70:101863.

• 越智雅之.
  サルコペニアとAGEs
  アンチ・エイジング医学 2026; 22:162-165.

• Nakashima I, Ohashi T, Yokoyama K, Kaida K, Nakahara J, Kondo T, Yoshikura N, Shimizu Y, Nohara C, Sakurai K, Yokote H, Niino M, Yamamura T, Fujihara K, Isobe N, Ochi H, Mori M, Kawachi I, Shimizu F, Kanda M, Tani Y, Fukazawa T
  A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.
  Mult Scler Relat Disord 2026; 107:107007

• Fujihara K, Isobe N, Miyamoto K, Niino M, Nakahara J, Hattori S, Tanaka M, Tahara M, Suzumura A, Sakurai K, Yoshikura N, Shiomi K, Ochi H, Nagata E, Deguchi K, Tomizawa Y, Yamashita K, Nagatsuka T, Adachi H, Nakashima I
  Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).
  Mult Scler 2026; 32:302-314.